CIK: 0001687078
Total reported value
$1.3B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | MDGL | Madrigal Pharmaceuticals INC | Stock-Healthcare | 7.54% | -6.45% | EXIT | |
| 2 | CGEM | Cullinan Therapeutics INC | Stock-Other | 7.42% | -0.67% | — | |
| 3 | RNAGBP | Avidity Biosciences INC | Stock-Other | 5.42% | — | — | |
| 4 | TRVI | Trevi Therapeutics INC | Stock-Other | 5.10% | -1.67% | — | |
| 5 | EWTX | Edgewise Therapeutics INC | Stock-Other | 4.57% | -0.66% | — | |
| 6 | PTCT | Ptc Therapeutics INC | Stock-Healthcare | 4.41% | -3.74% | EXIT | |
| 7 | ZLAB | Zai Lab Ltd-adr | Stock-Other | 4.13% | — | — | |
| 8 | SNDX | Syndax Pharmaceuticals INC | Stock-Other | 3.46% | -0.80% | — | |
| 9 | ORIC | Oric Pharmaceuticals INC | Stock-Other | 3.40% | +0.09% | — | |
| 10 | TARS | Tarsus Pharmaceuticals INC | Stock-Other | 3.32% | -1.29% | — | |
| 11 | XENE | Xenon Pharmaceuticals INC | Stock-Other | 3.31% | +0.15% | +55.66% | |
| 12 | STOK | Stoke Therapeutics INC | Stock-Other | 3.04% | -0.87% | — | |
| 13 | DYN | Dyne Therapeutics INC | Stock-Other | 3.00% | -1.18% | — | |
| 14 | CMPX | Compass Therapeutics INC | Stock-Other | 2.91% | — | -9.72% | |
| 15 | ALKS | Alkermes plc | Stock-Healthcare | 2.70% | — | — | |
| 16 | VERA | Vera Therapeutics INC | Stock-Other | 2.68% | — | — | |
| 17 | NTRA | Natera INC | Stock-Healthcare | 2.61% | -1.01% | — | |
| 18 | JANX | Janux Therapeutics INC | Stock-Other | 2.46% | — | — | |
| 19 | RVMD | Revolution Medicines INC | Stock-Healthcare | 2.41% | -0.80% | — | |
| 20 | CNTX | Context Therapeutics INC | Stock-Other | 2.33% | +0.36% | — | |
| 21 | SRPT | Sarepta Therapeutics INC | Stock-Healthcare | 2.21% | -0.17% | EXIT | |
| 22 | SPRY | Ars Pharmaceuticals INC | Stock-Other | 2.14% | — | — | |
| 23 | RCKT | Rocket Pharmaceuticals INC | Stock-Other | 2.08% | -0.64% | EXIT | |
| 24 | RLAY | Relay Therapeutics INC | Stock-Other | 1.95% | -0.35% | — | |
| 25 | RARE | Ultragenyx Pharmaceutical In | Stock-Other | 1.95% | — | — | |
| 26 | WVE | Wave Life Sciences Ltd. | Stock-Other | 1.80% | — | — | |
| 27 | DBVT | Dbv Technologies Sa-spon Adr | Stock-Other | 1.73% | +6.22% | — | |
| 28 | SLNOEUR | Soleno Therapeutics INC | Stock-Other | 1.66% | — | +200.00% | |
| 29 | SLDB | Solid Biosciences INC | Stock-Other | 1.65% | — | — | |
| 30 | AKBA | Akebia Therapeutics INC | Stock-Other | 1.29% | — | — | |
| 31 | HOWL | Werewolf Therapeutics INC | Stock-Other | 0.78% | -0.02% | — | |
| 32 | LQDA | Liquidia CORP | Stock-Other | 0.74% | -1.43% | — | |
| 33 | PVLA | Palvella Therapeutics INC | Stock-Other | 0.69% | -0.47% | — | |
| 34 | DSGN | Design Therapeutics INC | Stock-Other | 0.68% | — | — | |
| 35 | RNAC | Cartesian Therapeutics INC | Stock-Other | 0.64% | — | -44.61% | |
| 36 | ✓ | Engene Holdings INC | Stock-Other | 0.59% | -0.93% | — | |
| 37 | URGN | UroGen Pharma Ltd. | Stock-Other | 0.44% | -1.21% | — | |
| 38 | RAPP | Rapport Therapeutics INC | Stock-Other | 0.35% | — | — | |
| 39 | RPTX | Repare Therapeutics INC | Stock-Other | 0.24% | — | — | |
| 40 | ASMB | Assembly Biosciences INC | Stock-Other | 0.17% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | STOK | Stoke Therapeutics INC | +2.3% | — | Add |
| 2 | ORIC | Oric Pharmaceuticals INC | +2.1% | — | Add |
| 3 | MDGL | Madrigal Pharmaceuticals INC | +1.8% | — | Unchanged |
| 4 | RNAGBP | Avidity Biosciences INC | +1.8% | — | Add |
| 5 | XENE | Xenon Pharmaceuticals INC | +1.6% | +55.66% | Add |
| 6 | TRVI | Trevi Therapeutics INC | +1.4% | — | Trim |
| 7 | VERA | Vera Therapeutics INC | +1% | — | Add |
| 8 | RLAY | Relay Therapeutics INC | +0.9% | — | Trim |
| 9 | ALKS | Alkermes plc | +0.8% | — | Add |
| 10 | CNTX | Context Therapeutics INC | +0.8% | — | Unchanged |
| 11 | SLDB | Solid Biosciences INC | +0.6% | — | Trim |
| 12 | PTCT | Ptc Therapeutics INC | +0.6% | — | Trim |
| 13 | RVMD | Revolution Medicines INC | +0.5% | — | Trim |
| 14 | EWTX | Edgewise Therapeutics INC | +0.4% | — | Add |
| 15 | HOWL | Werewolf Therapeutics INC | +0.4% | — | Unchanged |
| 16 | DSGN | Design Therapeutics INC | +0.3% | — | Trim |
| 17 | RCKT | Rocket Pharmaceuticals INC | +0.2% | +0.01% | Add |
| 18 | CMPX | Compass Therapeutics INC | +0.2% | -9.72% | Trim |
| 19 | RARE | Ultragenyx Pharmaceutical In | -0.5% | — | Trim |
| 20 | SPRY | Ars Pharmaceuticals INC | -0.7% | — | Trim |
| 21 | ZLAB | Zai Lab Ltd-adr | -1.1% | — | Trim |
| 22 | RNAC | Cartesian Therapeutics INC | -1.2% | -44.61% | Trim |
| 23 | NTRA | Natera INC | -1.2% | — | Trim |
| 24 | CGEM | Cullinan Therapeutics INC | -2.5% | — | Unchanged |
| 25 | LNTH | Lantheus Holdings INC | — | EXIT | Sold out |
| 26 | CRNX | Crinetics Pharmaceuticals In | — | EXIT | Sold out |
| 27 | SNDX | Syndax Pharmaceuticals INC | — | NEW | New buy |
| 28 | TARS | Tarsus Pharmaceuticals INC | — | NEW | New buy |
| 29 | GH | Guardant Health INC | — | EXIT | Sold out |
| 30 | DYN | Dyne Therapeutics INC | — | NEW | New buy |
| 31 | UTHR | United Therapeutics CORP | — | EXIT | Sold out |
| 32 | SRPT | Sarepta Therapeutics INC | — | NEW | New buy |
| 33 | MLTX | Moonlake Immunotherapeutics | — | EXIT | Sold out |
| 34 | OLMA | Olema Pharmaceuticals INC | — | EXIT | Sold out |
| 35 | DBVT | Dbv Technologies Sa-spon Adr | — | NEW | New buy |
| 36 | 2662247D | Iteos Therapeutics INC | — | EXIT | Sold out |
| 37 | TWST | Twist Bioscience CORP | — | EXIT | Sold out |
| 38 | SLNOEUR | Soleno Therapeutics INC | — | NEW | New buy |
| 39 | REPL | Replimune Group INC | — | EXIT | Sold out |
| 40 | IOVA | Iovance Biotherapeutics INC | — | EXIT | Sold out |
| 41 | MBX | Mbx Biosciences INC | — | EXIT | Sold out |
| 42 | NUVB | Nuvation Bio INC | — | EXIT | Sold out |
| 43 | AKBA | Akebia Therapeutics INC | — | NEW | New buy |
| 44 | IDYA | Ideaya Biosciences INC | — | EXIT | Sold out |
| 45 | LQDA | Liquidia CORP | — | NEW | New buy |
| 46 | PVLA | Palvella Therapeutics INC | — | NEW | New buy |
| 47 | ✓ | Engene Holdings INC | — | NEW | New buy |
| 48 | VERUEUR | Veru INC | — | EXIT | Sold out |
| 49 | URGN | UroGen Pharma Ltd. | — | NEW | New buy |
| 50 | RAPP | Rapport Therapeutics INC | — | NEW | New buy |